STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Geoffrey Donnan, MD
The Florey Institute of Neuroscience and Mental Health
Principal Investigator - Henry Zhao, MD
Melbourne Health Dept of Neurology & The University of Melbourne Dept of Medicine
Principal Investigator - Stephen Davis, MD
Melbourne Health Dept of Neurology & The University of Melbourne Dept of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- John Hunter Hospital
New Lambton Heights, New South Wales, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- Gold Coast University Hospital
Southport, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Monash Medical Centre
Clayton, Victoria, Australia
- St Vincent'S Hospital Melbourne
Fitzroy, Victoria, Australia
- University Hospital Geelong
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Alfred Hospital
Melbourne, Victoria, Australia
- Royal Melbourne Hospital
Melbourne, Victoria, Australia
- Mobile Stroke Unit
Parkville, Victoria, Australia
- Helsinki University Hospital
Helsinki, Finland
- Cdhb Christchurch Hospital
Christchurch, New Zealand
- Palmerston North Hospital
Palmerston North, New Zealand
- Wellington Hospital
Wellington, New Zealand
- E-Da Hospital
Kaohsiung City, Yanchao District, Taiwan
- China Medical University Hospital
Taichung, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Bach Mai Hospital
Hanoi, Vietnam
- Military 103 Hospital
Hanoi, Vietnam
- Nguyen Tri Phuong Hospital
Ho Chi Minh City, Vietnam
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 19 Mar 2018
- Primary completion
- 28 May 2023
- Completion
- 28 May 2023
- Last update posted
- 28 Sept 2023
- Registered enrollment
- 201
- Registry id
- NCT03385928
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.